Inhibitory Effect of Astragalus Polysaccharides on Lipopolysaccharide-Induced TNF-a and IL-1β Production in THP-1 Cells
Open Access
- 12 March 2012
- Vol. 17 (3), 3155-3164
- https://doi.org/10.3390/molecules17033155
Abstract
Astragalus polysaccharides (APS), one of main bioactive components in Astragalus membranaceus Bunge, has been reported to possess anti-inflammatory activities, but the molecular mechanisms behind this activity are largely unknown. This study aimed to investigate expression of inflammatory cytokines and the MAPK/NF-κB pathway in human THP-1 macrophages induced by lipopolysaccharide (LPS). The results showed that the concentrations of TNF-a and IL-1β released from LPS stimulated THP-1 cells increased significantly compared to control (p < 0.01). After treatment with APS, the TNF-a and IL-1β levels were significantly lower than those in the LPS group (p < 0.05). The mRNA expression of TNF-a and IL-1β were also inhibited. Mechanistic studies indicated that APS strongly suppressed NF-κB activation and down-regulated the phosphorylation of ERK and JNK, which are important signaling pathways involved in the production of TNF-a and IL-1β, demonstrating that APS could suppress the production of TNF-a and IL-1β by LPS stimulated macrophages by inhibiting NF-κB activation and ERK and JNK phosphorylation.This publication has 35 references indexed in Scilit:
- A Novel Anti-Inflammatory Role for Ginkgolide B in Asthma via Inhibition of the ERK/MAPK Signaling PathwayMolecules, 2011
- Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugateArthritis Research & Therapy, 2011
- How macrophages mediate inflammatory pain via ATP signalingNature Reviews Rheumatology, 2010
- Therapeutic effects of astragalus polysaccharides on inflammation and synovial apoptosis in rats with adjuvant‐induced arthritisInternational Journal of Rheumatic Diseases, 2010
- The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational studyArthritis Research & Therapy, 2010
- Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signalingThe Journal of Experimental Medicine, 2008
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trialsAnnals Of The Rheumatic Diseases, 2008
- Receptor Activator of NF-κB Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6Molecular and Cellular Biology, 2002
- Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)Published by Elsevier BV ,1998
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996